In one such trial it was reported that in 97% of opiate-dependent and 87% of alcohol-dependent patients the symptoms were alleviated by DSIP administration.
A study found that in 97% of individuals struggling with opioid dependence and 87% of those battling alcohol dependence, symptoms were alleviated by administering DSIP.